Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Seroprevalence of Antibodies to Surface Antigens and Toxins of Clostridioides Difficile

NCT05192148 is registered in ClinicalTrials.gov with Fondation Hôpital Saint-Joseph as lead sponsor.

NCT NCT05192148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05192148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Seroprevalence of Antibodies to Surface Antigens and Toxins of Clostridioides Difficile
Lead sponsor
Fondation Hôpital Saint-Joseph
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2021
Completion date
December 30, 2024
Enrollment
840 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile infection